PERCEPTIVE ADVISORS LLC 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-03-06 4:15 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-2,099,952![]() (Position Closed) |
Filing |
2022-09-23 4:31 pm Purchase |
2022-09-16 | 13G | Relmada Therapeutics, Inc. RLMD |
PERCEPTIVE ADVISORS LLC | 2,099,952 7.000% |
2,099,952![]() (New Position) |
Filing |